Bioscience

Intrinsic Bioprobes announces issuance of US patent for novel biomarkers

October 29, 2010

By Flinn Foundation

[Source: Bioresearch Online] – Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.

For more information: Intrinsic Bioprobes Announces Issuance Of US Patent For Novel Biomarkers And Assays For Myocardial Infarction